This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Varughese, G. I Articles by Scarpello, J. H. Search for Related Content Social Bookmarking                         What's this?

Mortality rates in hospital patients with hyperglycaemia and MRSA bacteraemia

University Department of Medicine — ASCOT Centre City Hospital, Dudley Road, Birmingham, B18 7QH, UK

Kostos Miltsios

Department of Anaesthesiology, Rochdale Infirmary, Whitehall Street, Rochdale, OL12 0NB, UK

Harit N Buch

Diabetes Centre, New Cross Hospital, Wolverhampton, WV10 0QP, UK

Jeorge M Orendi

Department of Microbiology, University Hospital of North Staffordshire

John Hb Scarpello

Department of Diabetes and Endocrinology, University Hospital of North Staffordshire, Stoke-on-Trent, ST4 6QG, UK, John.Scarpello{at}uhns.nhs.uk

Methicillin Resistant Staphylococcus Aureus (MRSA) infections in the hospital population have shown a dramatic increase. This pilot study determined whether random/fasting blood glucose measurements were performed on patients admitted to hospital with MRSA bacteraemia. We also examined mortality in relationship to hyperglycaemia, defined as random glucose 11 mmol/L. Retrospective data for all in-patients aged 16 years for the three years; 2000—2002 identified 309 patients with MRSA bacteraemia and all of them had laboratory blood glucose concentrations recorded on admission in all cases. A random blood glucose 11 mmol/L was noted in 129 (42%) patients of whom 82 (64%) died. The mortality was significantly more likely to be in the highest tertile (p<0.05) of blood glucose distributions.

Key Words: MRSA (Methicillin Resistant Staphylococcus Aureus) • diabetes • infection • mortality • hyperglycaemia • bacteraemia.

References

• The first year of the Department of Health's mandatory MRSA bacteraemia surveillance scheme in acute NHS trusts in England: April 2001-March 2002. CDR Weekly 2002;12:1-17.
• Wallymahmed ME, Dawes S., Clarke G., Saunders S., Younis N., MacFarlane IA Hospital in-patients with diabetes: increasing prevalence and management problems. Diabet Med 2004;21:P191.
• Lambert PA Understanding MRSA. Br J Diabetes Vasc Dis 2004;4:47-8.[Free Full Text]
• Duckworth G. Controlling methicillin resistant Staphylococcus aureus: time to return to more stringent methods of control in the United Kingdom? BMJ 2003;327:1177-8.[Free Full Text]
• Griffiths C., Lamagni TL, Crowcroft NS, Duckworth G., Rooney C. Trends in MRSA in England and Wales: analysis of morbidity and mortality data for 1993-2002. Health Stat Q 2004;(21):15-22.[Medline] [Order article via Infotrieve]
• Commission for Health Improvement. Methicillin resistant Staphylococcus aureus (MRSA) improvement score. London: CHI, 2003. http://www.chi.nhs.uk/Ratings/Trust/Indicator
• Crowcroft NS, Catchpole M. Mortality from methicillin resistant Staphylococcus aureus in England and Wales: analysis of death certificates. BMJ 2002;325:1390-1.[Free Full Text]
• Tentolouris N., Jude EB, Smirnof I., Knowles EA, Boulton AJ Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic. Diabet Med 1999;16:767-71.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Turner JM, Hakeem LM, Lockman KA, Bhattacharyya DN, Campbell IW Diabetic MRSA foot infection - role of linezolid therapy. Br J Diabetes Vasc Dis 2004;4:44-6.[Abstract/Free Full Text]
• Coast J., Smith R., Karcher AM, Wilton P., Millar M. Superbugs II: how should economic evaluation be conducted for interventions, which aim to contain antimicrobial resistance? Health Econ 2002;11:637-47.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Philips BJ, Redman J., Brennan A. et al. Glucose in bronchial aspirates increases the risk of respiratory MRSA in intubate patients. Thorax 2005;60:761-4.[Abstract/Free Full Text]
• Pratt RJ, Pellow C., Loveday HP, Robinson N., Smith GW, and the EPIC guideline development team. The EPIC project: developing national evidence-based guidelines for preventing healthcare associated infections. J Hosp Infect 2001;47(suppl):3-4S.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

The British Journal of Diabetes & Vascular Disease, Vol. 6, No. 1, 42-44 (2006)
DOI: 10.1177/14746514060060010501


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Varughese, G. I Articles by Scarpello, J. H. Search for Related Content Social Bookmarking                         What's this?